Prosthetics- optune plus transducers
Ended Awarded Last action
- Contract number
- 36C26126N0361
- Awardee
-
Novocure Inc. UEI P3S3GK3DTUA8
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $49,749
Award facts
- Contract value 100% obligated
- $49,748.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Portsmouth, NH 03801, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a delivery order to Novocure Inc. on March 18, 2026, for the supply of Optune Plus transducers, medical devices that deliver Tumor Treating Fields therapy for cancer treatment. This firm fixed-price delivery order, valued at $49,748.73 with an ultimate completion date of June 17, 2026, carries no set-aside designation and will be performed at the Portsmouth, New Hampshire VA medical facility. The award leverages Novocure's primary Federal Supply Schedule contract (FSS-65-II-A) for Medical Equipment and Supplies, established November 1, 2022, with a total value of $28.85 million and a contract period extending through October 31, 2027.
Novocure Inc., a foreign-owned medical device manufacturer specializing in innovative cancer treatment technologies, serves as the prime contractor with no subcontractor involvement, ensuring direct quality control over its proprietary Optune system. The company has established itself as the exclusive provider of Tumor Treating Fields technology to the Veterans Health Administration, having issued over 100 delivery orders across multiple VISNs nationwide since the FSS contract's inception. This delivery order is consistent with the VA's broader strategic initiative to expand veterans' access to non-invasive cancer treatment options, with Novocure maintaining a demonstrated role as the sole-source provider of these specialized oncology solutions throughout the federal healthcare network.
Quick answers
Who was awarded contract 36C26126N0361?
36C26126N0361 was awarded to Novocure Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on March 18, 2026.
How much is contract 36C26126N0361 worth?
The government has obligated $49,749 on 36C26126N0361.
Is contract 36C26126N0361 an order under another contract?
Yes. 36C26126N0361 is a delivery order under 36F79723D0016, a federal supply schedule, on Medical Equipment and Supplies (FSS-65-II-A).
Was contract 36C26126N0361 competed?
The extent of competition for 36C26126N0361 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award